Almirall, S.A.
Almirall, S.A. (LBTSF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LBTSF · as of Jun 9, 2026
Key Statistics
Explore Almirall, S.A. Data
lbtsf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
lbtsf competitorsLBTSF
ARSUF
CASBF
CHSYF
CURLF
DMPHFStock Performance
Full HistoryAbout Almirall, S.A.
Almirall, S.A. is a biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of dermatology-focused pharmaceuticals. Its operations span Europe, the Un…
what is almirall, s.a. · lbtsf stock overview · almirall, s.a. company profile · who is almirall, s.a. ceo · lbtsf OTC · almirall, s.a. headquarters · almirall, s.a. business segments
About Stock Overview & Key Data
Almirall, S.A. (LBTSF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Aug 3, 2012. As of the latest trading session, LBTSF stock price is $15.35, with a market capitalization of $3.3B. The stock has returned +70.37% over the past 12 months and -0.78% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Almirall, S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Almirall, S.A. reported revenue of $1.1B and net income of $46.2M. For detailed data — including Almirall, S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Almirall, S.A. (LBTSF) stock price is $15.35. The stock is traded on OTC under the ticker symbol LBTSF. The 52-week range is $9.01 – $15.47.